Marie Blonski

Nancy, 54000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study.

CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study.

Journal: American journal of hematology

Published: February 06, 2026

Amino acid PET imaging to monitor mIDH inhibitor treatments in patients with refractory IDH-mutant gliomas.

Amino acid PET imaging to monitor mIDH inhibitor treatments in patients with refractory IDH-mutant gliomas.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 23, 2026

Prognostic Factors of IDH Wild-Type Glioblastoma After Extensive Surgery: A Multimodal Atlas of Tumor Locations, Recurrences and Management.

Prognostic Factors of IDH Wild-Type Glioblastoma After Extensive Surgery: A Multimodal Atlas of Tumor Locations, Recurrences and Management.

Journal: Cancers

Published: November 14, 2025

[177Lu]Lu-DOTATATE for refractory meningiomas: factors associated with the therapeutic response and initial tumor dosimetric data.

[177Lu]Lu-DOTATATE for refractory meningiomas: factors associated with the therapeutic response and initial tumor dosimetric data.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 05, 2025

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging.

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging.

Journal: EJNMMI research

Published: January 08, 2025

Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study.

Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study.

Journal: Journal of neuro-oncology

Published: October 06, 2024

Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma.

Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma.

Journal: Radiation oncology (London, England)

Published: June 02, 2024

DTI Analysis of the Peritumoral Zone of Diffuse Low-grade Gliomas in Progressing Patients.

DTI Analysis of the Peritumoral Zone of Diffuse Low-grade Gliomas in Progressing Patients.

Journal: World neurosurgery

Published: May 06, 2024

Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.

Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.

Journal: Journal of neuro-oncology

Published: April 24, 2024

Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.

Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.

Journal: Journal of neuro-oncology

Published: March 23, 2024

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

Journal: American journal of hematology

Published: November 27, 2023

The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.

The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 22, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026